Join our Newsletter — 33% off our NHI Course

How should healthcare organisations strengthen patient data security as interoperability expands across multiple systems and vendors?

Healthcare organisations should treat interoperability as a security design problem, not just a data-sharing goal. They need a complete view of where patient data lives, who can access it, and how access is governed across EHRs, cloud applications, and connected vendors. Without that visibility, compliance gaps, patient safety risks, and weak access controls are more likely to persist.

Securing interoperability starts with visibility, not just integration

When patient data moves across EHRs, cloud services, clearinghouses, and vendor platforms, the first security question is where data and access actually exist. Organisations need an accurate inventory of systems, interfaces, data flows, and trust relationships so they can see which connections expand the attack surface and which controls are missing at each handoff.

That visibility should extend to the data itself, not just the application layer. Patient records often pass through APIs, exports, messaging queues, and third-party workflows, so security teams need to understand which systems can read, transform, store, or forward protected information and which of those paths are directly exposed to outside parties.

Interoperability also changes the control model. A single access policy inside one platform is not enough if downstream systems inherit, duplicate, or cache patient data. The practical task is to map each integration to an accountable owner, the minimum necessary data set, and the specific approval or monitoring control that governs that relationship.

Access control must follow the data across every connected system

In interoperable environments, weak access management is usually the point where security breaks down. Organisations should be able to answer who is authorised to access patient data, under what conditions, and through which system of record that authorisation is enforced. If the same data is reachable through multiple vendors, the strongest control must not depend on the weakest one.

Least privilege matters more, not less, when integrations multiply. API scopes, service accounts, vendor credentials, and administrative roles should be tightly bounded to the exact records, functions, and environments required for the integration to work. Where possible, access should be time-limited, monitored, and reviewed separately from ordinary user access because machine-to-machine trust tends to drift without direct oversight.

Healthcare organisations should also treat shared authentication and shared tokens as high-value assets. A compromise in one connected platform can become a pathway into others if credentials, secrets, or tokens are reused across environments or vendors. That makes credential hygiene, rotation discipline, and isolation of integration credentials central to patient data protection.

Why vendor governance and data handling rules become the real security boundary

Interoperability is only as safe as the least mature partner in the chain. Every vendor that can receive, store, enrich, or retransmit patient data should be assessed for its own access controls, logging, retention practices, segmentation, and breach response capability. The organisation’s responsibility does not end when data leaves the core EHR.

Data-sharing agreements should therefore define more than permitted use. They should specify retention limits, subprocessor handling, incident notification, encryption expectations, segregation of customer data, and what must happen when an integration is retired or a vendor is replaced. Those lifecycle obligations are often where exposure accumulates, especially when integrations persist long after business need has changed.

Monitoring is equally important. If organisations cannot see what a vendor accessed, when it accessed it, and whether access matched the expected workflow, they cannot quickly distinguish legitimate interoperability from abnormal use. Logs, API audit trails, and exception handling need to be consistent enough to support both investigation and compliance evidence.

Risk and Threat Considerations

Interoperability widens the number of places where patient data can be exposed, copied, or misrouted. The main risk is not just unauthorised access in one system, but control drift across many systems that makes misuse harder to detect and easier to scale.

Failure mechanism: Weak API permissions, reused credentials, overbroad vendor access, or poor offboarding can allow one compromised integration to reach multiple datasets or move laterally across connected platforms.

Impact: The result can be patient data exposure, integrity errors in clinical workflows, delayed incident detection, and a larger remediation burden because every connected system must be reviewed, not just the one initially affected.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

CSA Cloud Controls Matrix, NIST CSF 2.0, NIST SP 800-53 Rev 5 and NIST Zero Trust (SP 800-207) set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.

Framework Control / Reference Relevance
CSA Cloud Controls Matrix IAM — Identity and Access Management Interoperability depends on controlling access across cloud and vendor systems.
DSP — Data Security and Privacy Patient data handling, retention, and sharing rules are central to interoperable flows.
Recommendation — Define vendor and system access boundaries, then enforce least privilege across all integrations. Classify patient data flows and apply handling, retention, and protection rules consistently.
NIST CSF 2.0 ID.AM-01 — Asset Inventory Security depends on knowing where patient data and integration points exist.
PR.AA-05 — Identity Management, Authentication and Access Control Access across connected systems must be governed consistently to limit exposure.
Recommendation — Maintain a current inventory of systems, interfaces, and data flows that carry patient data. Enforce tightly scoped access and review vendor and integration permissions regularly.
NIST SP 800-53 Rev 5 AC-6 — Least Privilege Least privilege is essential when multiple vendors and systems can reach patient data.
IA-5 — Authenticator Management Integration security depends on secure lifecycle control of secrets, tokens, and credentials.
Recommendation — Limit each integration and account to the minimum access required for its function. Rotate and protect integration credentials, tokens, and secrets on a defined schedule.
ISO/IEC 27001:2022 A.5.15 — Access control Interoperability requires consistent access governance across internal and external systems.
A.5.23 — Information security for use of cloud services Cloud-connected patient data flows need explicit governance and shared responsibility controls.
A.5.19 — Information security in supplier relationships Vendor integrations create third-party exposure that must be governed contractually and technically.
Recommendation — Set and enforce access rules for each connected system and vendor relationship. Define security requirements and monitoring for cloud services that process patient data. Assess supplier controls and verify they match the security needs of patient data sharing.
NIST Zero Trust (SP 800-207) Zero Trust Architecture Interoperable environments benefit from continuous verification and narrow trust assumptions.
Recommendation — Verify each connection explicitly and avoid assuming trust across system or vendor boundaries.

Practitioner Guidance

What to prioritise: Build a current integration inventory that links each data flow to its owner, purpose, access method, and vendor dependency. If you cannot trace a patient data path end to end, treat it as a control gap rather than an administrative nuisance.

What to verify: Confirm that integration access is separately governed from human user access, that secrets are rotated on a defined schedule, and that offboarding removes both data access and cached copies. The common mistake is assuming the contract is the control when the real control is the technical enforcement.

Practitioner takeaway: Interoperability is safest when every connection has a clear owner, a narrow trust boundary, and an auditable access model; if those three are missing, patient data security will degrade as the ecosystem grows.